You Suck Wind. We're Here to Help.


Around Christmas 2012 I came into a chunky quarterly bonus about $5K more than I expected, which for me at the time was a small windfall. Just enough unexpected cash, I thought, to make it worth investing in French company Alcatel-Lucent that I’d been watching for a while. I purchased nearly 6,000 shares for around 84 cents apiece.

The stock continued rising through January, but a gradual descent pulled its share price from a New Year high of around a buck-thirty to just above a dollar in May 2013.

It was a roller coaster and after the money was sloshing around a bit, looking back at me from my trading account, it no longer felt so easy come, easy go.

I guess my stress finally peaked because then I sucked wind. I sold in May, about six months after buying, easing my self-doubt with the fact that a $900 profit was nothing to be ashamed of.

Sadly for me, if I’d sold in January, a month after my buy, I’d have pocketed $2,300. And if I’d held my shares until April 2015 and sold, I’d have banked nearly three times my bonus – and collected a $14,950 profit.

We suck wind so badly that even had I taken a blow to my head, lost my faculties and lay deep in a coma until now (the only way my nerves would have lasted holding this long) I’d be telling you from the hospital that I collected $13,250 on my $5,000 bet three years ago. Only because I couldn’t screw up the outcome.

You get my point.

It’s impossible to miss because it’s so true. We can’t be trusted with our emotions to act logically in these situations and that’s why Adam O’Dell’s Cycle 9 Alert is so popular, and so successful.

To better explain the simple ways investors can avoid the pitfalls that trip us up, and lose us money, Adam’s publishing a webinar on key concepts that can tilt the market’s odds back in your favor.

Because this information is normally part of our paid subscription services, we’re asking those of you who wish to join Adam for his webinar to sign up with us to ensure your spot, because this isn’t something we do often, and it’s likely something that you don’t want to miss. You can look out for how to do that next Wednesday.

In the meantime, here’s a look back at what we talked about at Dent Research this week…

Monday Harry re-visited his concernrns over China’s ever-expanding real estate bubble. While he’d written previously about Shenzen’s 80% year-over-year residential property price increases and Shanghai’s slightly more modest 65% Yo-Yo rise, a new piece of analysis gave us pause. China’s bank losses could exceed those of the subprime crisis by about 400% – potentially requiring a $10 trillion bailout.

Tuesday it was Charles writing from Lima, Peru, where he’s now left his in-law’s horse ranch to spend the remaining summer in the city with family, who outlined how to go about preparing for investment in your kids’ college fund. With college tuition rising over 1100% for nearly 40 years… you’ll likely want one.

Wednesday from the frontlines, our in-house Marine officer, Ben Benoy, took note of a potentially disruptive alliance that may shake up the pharmaceutical industry. Google’s parent company Alphabet (Nasdaq: GOOGL) announced its partnership with GlaxoSmithKline to launch a new “bioelectronics medicine” company. A four-year, $710 million cash dispersion will get the new partners started.

Thursday Lance helped us firm up our understanding of the Fed’s actual Congressional mandate and the five general tasks it’s authorized to perform. Today’s type of shenanigans are nowhere to be found, at least not that I saw. Interpretations seem to have clearly gone askew.

Friday came more quickly than expected when John reminded us that not only are dividends sweet as Tupelo honey, but that not all dividends are equal. He offered some brilliant examples with a couple well-know companies. One does dividends right and another you’d never expect… clearly does not.

And that brought one more week of summer 2016 to an end. Thank you for spending some of that time with us here at Dent Research.

Play safe out there,

Robert Johnson Signature




Robert Johnson

Editorial Director, Dent Research